发明名称 |
DENGUE VIRUS E-GLYCOPROTEIN POLYPEPTIDES CONTAINING MUTATIONS THAT ELIMINATE IMMUNODOMINANT CROSS-REACTIVE EPITOPES |
摘要 |
Described herein are dengue virus E-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes associated with immune enhancement. The disclosed dengue virus E-glycoproteins optionally further include mutations that introduce a strong CD4 T cell epitope. The disclosed E-glycoprotein polypeptides, or nucleic acid molecules encoding the polypeptides, can be used, for example, in monovalent or tetravalent vaccines against dengue virus. The dengue virus E-glycoprotein polypeptides have amino acid substitutions at residues corresponding to positions 106, 107, 310 and 31 1, and either position 364 or position 389 of dengue serotype 1 (DENV- l) E- glycoprotein. The provided E-glycoprotein polypeptides optionally further include mutations corresponding to positions 468, 478, 482 and 487 of DENV-1 E-glycoprotein. |
申请公布号 |
CA2852684(A1) |
申请公布日期 |
2013.04.25 |
申请号 |
CA20122852684 |
申请日期 |
2012.10.18 |
申请人 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA ASREPRESENTED BY THE SECRETARY OF THE DEPARTMENT OFHEALTH AND HUMAN SERVICES |
发明人 |
CHANG, GWONG-JEN J.;CRILL, WAYNE D.;HUGHES, HOLLY R.;DAVIS, BRENT S. |
分类号 |
C07K14/18;A61K39/12;A61K39/295;C12N15/40 |
主分类号 |
C07K14/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|